This week Hexoskin is in Boston to attend the 3rd Annual Mobile in Clinical Trials on September 19th and the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on September 20-21, 2016 in Boston. This annual event sponsored by Hexoskin is an opportunity for the Life Science industry to share the latest thinking, insights, and updates on the application of disruptive and mobile technologies to advance clinical research and drug development.
On September 20th, Pierre-Alexandre Fournier, CEO and Co-Founder of Hexoskin will present how clinical grade wearable sensors like Hexoskin is used for long-term remote monitoring in clinical trials. He will also share with the participants some use cases involving Hexoskin for monitoring patients in clinical research, and share lessons learned & best practices.
Additionally, Hexoskin will demonstrate its technology in the exhibition hall of the conference on September 20-21st (booth #35). The Hexoskin team will present how Hexoskin can be used in clinical development with live demos and presentations.
We're very excited to join world-class innovators at DPharm to discuss and reflect on how disruptive technologies like Hexoskin will change the landscape of clinical trials.
If you're in Boston come visit us on September 20-21st!
September 19, 2016: Mobile in Clinical Trials (Boston)
September 20-21, 2016: DPharm (Boston) - Disruptive Innovation to Advance Clinical Trials Conference
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world, providing a new, convenient way to understand human health in real-life environments. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.
Wondering how you can turn Hexoskin data into ready-to-publish graphs?
You're in luck, Hexoskin is announcing its compatibility with VivoSense, the most comprehensive physiological data analysis software available for health research and clinical studies. It allows researchers and scientists to import and export data, execute batch processing, and produce meaningful and ready-to-publish graphs of study results.
VivoSense's 400+ customers include organizations like the Mayo Clinic, the Massachusetts General Hospital, MIT, and US Army and Air Force research labs. VivoSense is a validated platform and is 21 CFR Part 11 compliant and specifically designed for use in clinical trials and research studies.
VivoSense core software and modules are available from Hexoskin today.
Check out How to Manage and Publish Hexoskin Data